These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35753818)

  • 1. Delayed eczematous skin reaction as an adverse drug reaction to immunoglobulin infusions: A case series.
    Barthel C; Musquer M; Veyrac G; Bernier C
    Ann Dermatol Venereol; 2022 Dec; 149(4):264-270. PubMed ID: 35753818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy.
    Gerstenblith MR; Antony AK; Junkins-Hopkins JM; Abuav R
    J Am Acad Dermatol; 2012 Feb; 66(2):312-6. PubMed ID: 21601310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pompholyx as a side effect of intravenous immunoglobulin (IVIg).
    Doyle C; Eustace K
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: a paediatric case.
    Brazzelli V; Grassi S; Savasta S; Ruffinazzi G; Carugno A; Barbaccia V; Marseglia GL; Borroni G
    Int J Immunopathol Pharmacol; 2014; 27(1):127-30. PubMed ID: 24674688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature.
    Vecchietti G; Kerl K; Prins C; Kaya G; Saurat JH; French LE
    Arch Dermatol; 2006 Feb; 142(2):213-7. PubMed ID: 16490849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.
    Takci Z; Guler Simsek G; Uzuner H; Akbayrak A; Yıldız Seckin H; Karadag AS
    Dermatol Ther; 2020 Nov; 33(6):e14147. PubMed ID: 32767429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eczematous reactions after intravenous immunoglobulin therapy in two patients with Guillain-Barré syndrome and a patient with Miller Fisher syndrome].
    Tada M; Tada M; Ishiguro H; Yagi E; Hirota K
    No To Shinkei; 2003 May; 55(5):401-5. PubMed ID: 12833881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study.
    Cohen Aubart F; Barete S; Amoura Z; Francès C; Lyon-Caen O; Lebrun-Vignes B
    Eur J Intern Med; 2009 Jan; 20(1):70-3. PubMed ID: 19237096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study.
    Voland P; Barthel C; Azzouz B; Raison-Peyron N; Du-Thanh A; Staumont-Sallé D; Jachiet M; Soria A; Nosbaum A; Valois A; Leleu C; Lebrun-Vignes B; Trenque T; Hettler D; Bernier C; Viguier M;
    J Am Acad Dermatol; 2023 Feb; 88(2):380-387. PubMed ID: 36252685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin-induced severe vesicular eczematous eruption successfully treated with narrow band-ultraviolet B therapy.
    Koizumi R; Fukumoto T; Jimbo H; Nishigori C
    Photodermatol Photoimmunol Photomed; 2021 Sep; 37(5):371-373. PubMed ID: 33559335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy.
    Uyttendaele H; Obadiah J; Grossman M
    J Drugs Dermatol; 2003 Jun; 2(3):337-41. PubMed ID: 12848120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement.
    Ibis IBP; Erdur B; Erdem SB; Karaman S; Gulez N; Genel F
    Allergol Immunopathol (Madr); 2020; 48(6):738-744. PubMed ID: 32703652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous immunoglobulin-induced eczematous eruption in autoimmune neuromuscular diseases].
    Hatake S; Shimizu F; Honda M; Takahashi S; Koga M; Kimura K; Kanda T
    Rinsho Shinkeigaku; 2022 Apr; 62(4):267-271. PubMed ID: 35354723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monthly low-dose immunoglobulin infusion as a maintenance therapy for multifocal motor neuropathy may reduce allergic adverse effects: a case report].
    Murata Y; Okamoto T; Kondo Y; Chihara N; Furusawa Y; Murata M
    Rinsho Shinkeigaku; 2010 Aug; 50(8):561-5. PubMed ID: 20803965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Observational Study of Adverse Reactions Associated With Intravenous Immunoglobulin Infusion.
    Kato H; Hayashi M; Ohashi W; Yamaguchi T; Tanaka S; Kozono A; Gao S; Katai A; Niwa R; Matsuo T; Ishiyama K; Ando T; Ogawa M; Nakayama T
    Front Immunol; 2021; 12():740517. PubMed ID: 34603326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyshidrotic eczema associated with the use of IVIg.
    Kotan D; Erdem T; Acar BA; Boluk A
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23417935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eczematous reaction to IVIG for the treatment of dermatomyositis.
    Berk-Krauss J; Lee K; Lo Sicco KI; Liebman TN
    Int J Womens Dermatol; 2018 Sep; 4(3):170-173. PubMed ID: 30175220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lichenoid/Interface cutaneous eruptions to IVIg with the primary infusion may be related to the re-regulation of anti-idiotype network.
    Smith KJ; Dutka AL; Skelton HG
    J Cutan Med Surg; 1998 Oct; 3(2):96-101. PubMed ID: 9822784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin G use and pharmacovigilance in a tertiary care children's hospital.
    Yori S; Belleri F; Testard J; Fierro Vidal Á; Rousseau M
    Arch Argent Pediatr; 2021 Jun; 119(3):192-197. PubMed ID: 34033419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Reactions to Intravenous Immunoglobulins - Our Experience.
    Kareva L; Mironska K; Stavric K; Hasani A
    Open Access Maced J Med Sci; 2018 Dec; 6(12):2359-2362. PubMed ID: 30607191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.